Rokan N, Reddy D
BJUI Compass. 2025; 6(2):e70000.
PMID: 39980983
PMC: 11840424.
DOI: 10.1002/bco2.70000.
Wehrenberg-Klee E, Hampilos P, Austin E, Ataeinia B, MacPherson A, LaSalle T
Radiol Imaging Cancer. 2024; 6(6):e230187.
PMID: 39485112
PMC: 11615628.
DOI: 10.1148/rycan.230187.
Zhao H, Du F, Xiang X, Tang Y, Feng Z, Wang Z
Ultrason Sonochem. 2024; 111:107105.
PMID: 39427436
PMC: 11533716.
DOI: 10.1016/j.ultsonch.2024.107105.
Tao X, Li S, Wu H, Jin F, Jin G, Wu L
Children (Basel). 2024; 11(9).
PMID: 39334662
PMC: 11430481.
DOI: 10.3390/children11091130.
Ciambella C, Takabe K
World J Oncol. 2024; 15(5):737-743.
PMID: 39328333
PMC: 11424111.
DOI: 10.14740/wjon1909.
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial.
Mooradian M, Fintelmann F, LaSalle T, Simon J, Graur A, Muzikansky A
Nat Commun. 2024; 15(1):7357.
PMID: 39191779
PMC: 11349953.
DOI: 10.1038/s41467-024-51722-x.
Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid Tumors.
Holtermann A, Gislon M, Angele M, Subklewe M, von Bergwelt-Baildon M, Lauber K
BioDrugs. 2024; 38(5):611-637.
PMID: 39080180
PMC: 11358237.
DOI: 10.1007/s40259-024-00669-y.
New insights into mechanisms and interventions of locoregional therapies for hepatocellular carcinoma.
Liu H, Wang C, Wang R, Cao H, Cao Y, Huang T
Chin J Cancer Res. 2024; 36(2):167-194.
PMID: 38751435
PMC: 11090796.
DOI: 10.21147/j.issn.1000-9604.2024.02.06.
Modern cancer therapy: cryoablation meets immune checkpoint blockade.
Liu Q, Zhang C, Chen X, Han Z
Front Oncol. 2024; 14:1323070.
PMID: 38384806
PMC: 10881233.
DOI: 10.3389/fonc.2024.1323070.
Endoscopic spray cryotherapy for dysphagia palliation in esophageal cancer: Systematic review and meta-analysis.
Gopakumar H, Khan H, Sharma N, Puli S
Endosc Int Open. 2024; 12(2):E211-E217.
PMID: 38348331
PMC: 10861318.
DOI: 10.1055/a-2231-7328.
Radiotherapy, photodynamic therapy, and cryoablation-induced abscopal effect: Challenges and future prospects.
Ali Mohammad S, Hak A, Pogu S, Rengan A
Cancer Innov. 2023; 2(5):323-345.
PMID: 38090387
PMC: 10686191.
DOI: 10.1002/cai2.53.
Current Perspectives of Immunotherapy for Hepatocellular Carcinoma.
Liu X, Lei X, Huang S, Yang X
Comb Chem High Throughput Screen. 2023; 28(2):185-201.
PMID: 38031784
DOI: 10.2174/0113862073255266231025111125.
Preliminary Results of Preoperative Planning Using 3D Printing and Augmented Reality in Cryotherapy Treatment of Giant Cell Tumor of Bone-CRIO2AR Project.
DArienzo A, Scognamiglio B, Campo F, Cosseddu F, Ruinato D, Ipponi E
Healthcare (Basel). 2023; 11(19).
PMID: 37830669
PMC: 10572172.
DOI: 10.3390/healthcare11192629.
Cryoablation and immunity in non-small cell lung cancer: a new era of cryo-immunotherapy.
Velez A, DeMaio A, Sterman D
Front Immunol. 2023; 14:1203539.
PMID: 37671163
PMC: 10475831.
DOI: 10.3389/fimmu.2023.1203539.
Effects of Inflammatory Cell Death Caused by Catheter Ablation on Atrial Fibrillation.
Liu D, Li Y, Zhao Q
J Inflamm Res. 2023; 16:3491-3508.
PMID: 37608882
PMC: 10441646.
DOI: 10.2147/JIR.S422002.
Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials.
Jiang M, Fiering S, Shao Q
Front Oncol. 2023; 13:1153066.
PMID: 37251920
PMC: 10211342.
DOI: 10.3389/fonc.2023.1153066.
Cryoablation and Immunotherapy: An Enthralling Synergy for Cancer Treatment.
Medlej Z, Medlej W, Slaba S, Torrecillas P, Cueto A, Urbaneja A
Curr Oncol. 2023; 30(5):4844-4860.
PMID: 37232823
PMC: 10217386.
DOI: 10.3390/curroncol30050365.
The analysis of immunogenic cell death induced by ablation at different temperatures in hepatocellular carcinoma cells.
Wang M, Duan Y, Yang M, Guo Y, Li F, Wang J
Front Cell Dev Biol. 2023; 11:1146195.
PMID: 37187618
PMC: 10175605.
DOI: 10.3389/fcell.2023.1146195.
Treatment of Hepatocellular Carcinoma by Multimodal In Situ Vaccination Using Cryoablation and a Plant Virus Immunostimulant.
Ghani M, Bangar A, Yang Y, Jung E, Sauceda C, Mandt T
J Vasc Interv Radiol. 2023; 34(7):1247-1257.e8.
PMID: 36997021
PMC: 10829876.
DOI: 10.1016/j.jvir.2023.03.016.
tumor vaccination by percutaneous ablative therapy and its synergy with immunotherapeutics: An update on combination therapy.
Kim N, Yoon J, Tuomi A, Lee J, Kim D
Front Immunol. 2023; 14:1118845.
PMID: 36969248
PMC: 10030508.
DOI: 10.3389/fimmu.2023.1118845.